Forecast & RatingOnly 1 analyst currently covers Calidi Biotherapeutics (CLDI.US), with a price target of $1920.08 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Jul 31, 2026; this does not constitute investment advice.
Jul 22, 2025Price forecast
$1920.08176053.83%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met0.0%
Stock price$1.09
Avg. target$1,920.1
High target$1,920
Low target$1,920
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.